Saltar al contenido
Merck

The roles of JAK2/STAT3 signaling in fusion of the secondary palate.

Disease models & mechanisms (2023-10-17)
Naoki Yoshida, Toshihiro Inubushi, Takumi Hirose, Gozo Aoyama, Hiroshi Kurosaka, Takashi Yamashiro
RESUMEN

Cleft palate has a multifactorial etiology. In palatal fusion, the contacting medial edge epithelium (MEE) forms the epithelial seam, which is subsequently removed with the reduction of p63. Failure in this process results in a cleft palate. We herein report the involvement of janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling in palatal fusion and that folic acid rescues the fusing defect by reactivating JAK2/STAT3. In closure of bilateral palatal shelves, STAT3 phosphorylation was activated at the fusing MEE and mesenchyme underlying the MEE. JAK2 inhibition by AG490 inhibited STAT3 phosphorylation and resulted in palatal fusion failure without removal of the epithelial seam, in which p63 and keratin 17 (K17) periderm markers were retained. Folic acid application restored STAT3 phosphorylation in AG490-treated palatal explants and rescued the fusion defect, in which the p63- and K17-positive epithelial seam were removed. The AG490-induced palatal defect was also rescued in p63 haploinsufficient explants. These findings suggest that JAK2/STAT3 signaling is involved in palatal fusion by suppressing p63 expression in MEE and that folate restores the fusion defect by reactivating JAK2/STAT3.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
AG490, InSolution, ≥98%, inhibitor of EGFR kinase autophosphorylation